Trade Summary

5 days ago, Thompson Elizabeth H.Z., serving as EVP, Head of Research & Dev at ACADIA PHARMACEUTICALS INC (ACAD), sold 16,558 shares at $26.13 per share, for a total transaction value of $432,662.54. Following this transaction, Thompson Elizabeth H.Z. now holds 18,994 shares of ACAD.

This sale represents a 46.57% decrease in Thompson Elizabeth H.Z.'s stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, July 30, 2026 and publicly disclosed via SEC Form 4 filing on Friday, July 31, 2026 at 6:00 PM ET, 1 day after the trade was made.

ACADIA PHARMACEUTICALS INC operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.